Practical Psychotherapy (November/December)

Date of Issue: 11/01/2020 | Volume: 18 | Number: 11&12

Issue Links:Learning Objectives | Editorial Information

In this issue on practical psychotherapy, brief therapy with med E&M is spotlighted. For our QA interviews, Donna Sudak blends CBT with the medication visit while Michael Linden shows us how to watch out for psychotherapy side effects. Plus: How to select an SSRI; when to use ramelteon; good news for benzos and transcranial direct current stimulation and not-so-good news for beta-blockers.

In This Issue

Clinical Update

Is Ramelteon an Effective Hypnotic?

Topics: Belsomra | Benzodiazepines | Geriatric Psychiatry | Hypnotics | Lemborexant | Melatonin | Sleep | Suvorexant

Ramelteon (Rozerem) is one of the safer sleep medications, but how well does its efficacy stack up against other hypnotics? The answer surprised us.

Read More
Expert Q&A

Side Effects of Psychotherapy

Topics: Behavior therapy | Behavioral therapy | Behavioral treatment | Brief psychotherapy | Cognitive Behavioral Therapy | Exercise | Psychotherapy | Therapy during medication appointment | Therapy with Med Management

Psychotherapy can work as well as medication, but can it also have side effects? Michael Linden believes it can. He launched some of the key studies that brought light to this under-appreciated phenomenon, and in this interview he shows us how to recognize and avoid them.

Read More
Expert Q&A

Brief Therapy During the Medication Visit

Topics: Behavior therapy | Behavioral therapy | Behavioral treatment | Brief psychotherapy | Cognitive Behavioral Therapy | Exercise | Psychotherapy | Therapy during medication appointment | Therapy with Med Management

Every minute counts in the 90833 “brief therapy with medication” visit, and Donna Sudak shows us how to customize CBT with pharmacotherapy for depression, bipolar, anxiety disorders, and schizophrenia.

Read More

How to Select an SSRI

Topics: Antidepressants | Citalopram | Escitalopram | Fluoxetine | Prozac | Psychopharmacology | Psychotropic medication | Serotonin Specific Reuptake Inhibitors (SSRIs) | Sertraline | SSRIs

After digging through 3 decades of research, we can tell you this: There is no such thing as “the best” SSRI. But there are some important differences between them, and this article will show you how to find the right one for your patient.

Read More
Brief Clinical Update

Metformin ER Recalled Due to Cancer Risk

Topics: Antipsychotics | Generics | Metformin | Weight gain | Weight Loss Medications

Generic metformin is being recalled by the batches, but is any of it still safe to prescribe?

Read More
In Brief

Chemical Exposures

Two recent studies add to the mounting evidence that environmental toxins deserve a place in the bio-psycho-social-spiritual model. The first study correlated ADHD symptoms with exposure to endocrine-disrupting chemicals found in plastics, pesticides, and processed food. The second study was a meta-analysis of ultra-processed food consumption from 23 cross-sectional and prospective cohort studies.

Read More
Research Update

Beta Blockers and Depression: The Controversy Revisited

Topics: Medical Comorbidities

Antihypertensives are among the world’s most widely prescribed drugs, but many of them impact pathways associated with depression. Beta blockers have long been believed to cause depression, but most of these studies were carried out decades ago and their findings have been inconsistent.

Read More
Research Update

Transcranial Direct-Current Stimulation in Depression Reconsidered

Topics: Brain Devices | Depression

The case builds for this DIY antidepressant device.

Read More
CME Post-Test

CME Post-Test - Practical Psychotherapy, TCPR, November/December 2020

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.

Read More